...
首页> 外文期刊>Critical reviews in oncology/hematology >Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer.
【24h】

Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer.

机译:血清和组织生物标志物作为上皮性卵巢癌的预测和预后变量。

获取原文
获取原文并翻译 | 示例
           

摘要

Tumour stage, residual disease after initial surgery, histological type and tumour grade are the most important clinical-pathological factors related to the clinical outcome of patients with epithelial ovarian cancer. In the last years, several investigations have assessed different biological variables in sera and in tissue samples from patients with this malignancy in order to detect biomarkers able to reflect either the response to chemotherapy or survival. The present paper reviewed the literature data about the predictive or prognostic relevance of serum CA 125, soluble cytokeratin fragments, serum human kallikreins, serum cytokines, serum vascular endothelial growth factor and plasma d-dimer as well as of tissue expression of cell cycle- and apoptosis-regulatory proteins, human telomerase reverse transcriptase, membrane tyrosine kinase receptors and matrix metalloproteinases. A next future microarray technology will hopefully offer interesting perspectives of translational research for the identification of novel predictive and prognostic biomarkers for epithelial ovarian cancer.
机译:肿瘤分期,初次手术后残留疾病,组织学类型和肿瘤等级是与上皮性卵巢癌患者临床结果相关的最重要的临床病理因素。近年来,一些研究评估了患有这种恶性肿瘤的患者血清和组织样本中的不同生物学变量,以检测能够反映对化学疗法或生存反应的生物标志物。本文综述了有关血清CA 125,可溶性细胞角蛋白片段,血清人激肽释放酶,血清细胞因子,血清血管内皮生长因子和血浆d-二聚体的预测或预后相关性的文献资料,以及与细胞周期和凋亡调节蛋白,人类端粒酶逆转录酶,膜酪氨酸激酶受体和基质金属蛋白酶。下一个未来的微阵列技术有望为转化研究提供有趣的观点,以鉴定上皮性卵巢癌的新型预测性和预后性生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号